Max Robotics — Global Service Robot Directory + US Certification

About

John F. Swietlik is a pioneering biomedical engineer whose research centers on noninvasive cancer therapies, specifically histotripsy and robotically assisted sonic therapy (RAST). His major contributions lie in developing and validating image-guided, robotic systems for precise, nonthermal tissue ablation. Swietlik’s work has demonstrated the feasibility of using histotripsy—a nonionizing, noninvasive focal therapy—to treat deep-seated tumors in the liver and kidney, while mitigating collateral damage to surrounding tissues. His most cited paper, “Robotically-Assisted Sonic Therapy for Renal Ablation in a Live Porcine Model” (47 citations), established initial preclinical proof-of-concept. He further advanced the field by introducing a modified pulse sequence to reduce body wall damage during hepatic ablation (44 citations) and by pioneering X-ray C-arm and cone beam CT guidance for targeting histotripsy, addressing the critical limitation of ultrasound for deep or isoechoic lesions. Swietlik’s work has accumulated over 140 citations, reflecting its impact on the transition of histotripsy from bench to bedside. His research is instrumental in shaping the future of noninvasive, image-guided cancer therapy, offering hope for safer, more precise treatments.